Cost-effectiveness of Daratumumab-based Triplet Therapies in Patients With Relapsed or Refractory Multiple Myeloma

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (71704064)
  • Natural Science Foundation of Guangdong Province, China (2017A030310174)
  • Fundamental Research Funds for the Central Universities (21616324)

This publication has 42 references indexed in Scilit: